{"id":8107,"date":"2025-11-04T23:02:50","date_gmt":"2025-11-04T23:02:50","guid":{"rendered":"https:\/\/mailitics.com\/index.php\/2025\/11\/04\/glp-1-microdosing-ai-medical-coding-health-tech\/"},"modified":"2025-11-04T23:02:50","modified_gmt":"2025-11-04T23:02:50","slug":"glp-1-microdosing-ai-medical-coding-health-tech","status":"publish","type":"post","link":"https:\/\/mailitics.com\/index.php\/2025\/11\/04\/glp-1-microdosing-ai-medical-coding-health-tech\/","title":{"rendered":"STAT+: News you need to know about AI medical coding and GLP-1 microdosing"},"content":{"rendered":"

STAT+: News you need to know about AI medical coding and GLP-1 microdosing
\n \t

\n
<\/BR>
\n
\n \t

\n
<\/BR><\/p>\n

\n

You\u2019re reading the web edition of STAT\u2019s Health Tech newsletter, our guide to how technology is transforming the life sciences.\u00a0Sign up to get it<\/a>\u00a0delivered in your inbox every Tuesday and Thursday.<\/em><\/p>\n

Telehealth companies Noom, Found, and Hims & Hers have all recently launched programs to prescribe \u201cmicrodosed\u201d GLP-1s. The companies say that in small doses the drugs can provide myriad health benefits, but as Katie Palmer reports<\/a>, there\u2019s no robust evidence of these marketing claims. The strategy is the latest effort by telehealth companies and their compounding pharmacy partners to extend the runway to profit off of the popular diabetes and obesity drugs.<\/p>\n

Read more here<\/a><\/p>\n

Continue to STAT+ to read the full story\u2026<\/a><\/p>\n<\/div>\n

\t

\n
<\/BR>
\n Mario Aguilar
\n \t

\n
<\/BR>
\nGo to statnews<\/a>
\n \t

\n
<\/BR><\/p>\n","protected":false},"excerpt":{"rendered":"

STAT+: News you need to know about AI medical coding and GLP-1 microdosing You\u2019re reading the web edition of STAT\u2019s Health Tech newsletter, our guide to how technology is transforming the life sciences.\u00a0Sign up to get it\u00a0delivered in your inbox every Tuesday and Thursday. Telehealth companies Noom, Found, and Hims & Hers have all recently […]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[69,2194,2217,2318,2176],"tags":[2150],"class_list":["post-8107","post","type-post","status-publish","format-standard","hentry","category-artificial-intelligence","category-biotech","category-health-tech","category-health-tech-newsletter","category-pharma","tag-statnews"],"_links":{"self":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/posts\/8107"}],"collection":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/comments?post=8107"}],"version-history":[{"count":0,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/posts\/8107\/revisions"}],"wp:attachment":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/media?parent=8107"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/categories?post=8107"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/tags?post=8107"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}